CA2612044C - Capsule contenant un emetique - Google Patents

Capsule contenant un emetique Download PDF

Info

Publication number
CA2612044C
CA2612044C CA2612044A CA2612044A CA2612044C CA 2612044 C CA2612044 C CA 2612044C CA 2612044 A CA2612044 A CA 2612044A CA 2612044 A CA2612044 A CA 2612044A CA 2612044 C CA2612044 C CA 2612044C
Authority
CA
Canada
Prior art keywords
emetic
drug
capsule
hard capsule
embedded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2612044A
Other languages
English (en)
Other versions
CA2612044A1 (fr
Inventor
Paul Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2612044A1 publication Critical patent/CA2612044A1/fr
Application granted granted Critical
Publication of CA2612044C publication Critical patent/CA2612044C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2612044A 2005-06-13 2006-06-13 Capsule contenant un emetique Expired - Fee Related CA2612044C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69002305P 2005-06-13 2005-06-13
US60/690,023 2005-06-13
PCT/US2006/022939 WO2006138278A1 (fr) 2005-06-13 2006-06-13 Capsule contenant un émétique

Publications (2)

Publication Number Publication Date
CA2612044A1 CA2612044A1 (fr) 2006-12-28
CA2612044C true CA2612044C (fr) 2016-02-02

Family

ID=37570767

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2612044A Expired - Fee Related CA2612044C (fr) 2005-06-13 2006-06-13 Capsule contenant un emetique

Country Status (4)

Country Link
EP (1) EP1893183A4 (fr)
JP (1) JP2008543851A (fr)
CA (1) CA2612044C (fr)
WO (1) WO2006138278A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2919892C (fr) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Comprime extrude anti-abus a liberation immediate
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (fr) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération prolongée
CA2910865C (fr) 2014-07-15 2016-11-29 Isa Odidi Compositions et methodes destines a reduire les surdoses
EP3169315B1 (fr) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Forme posologique remplie de liquide anti-abus à libération immédiate
WO2016064873A1 (fr) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Forme galénique anti-abus de remplissage de liquide à libération prolongée

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1428361A (en) * 1972-02-15 1976-03-17 Grant A Safeguarded medicinal compositions
IE46306B1 (en) * 1977-02-11 1983-05-04 Ici Ltd Safeguarded toxic chemical compositions containing an emetic
US4175119A (en) * 1978-01-11 1979-11-20 Porter Garry L Composition and method to prevent accidental and intentional overdosage with psychoactive drugs
US4529583A (en) * 1983-03-07 1985-07-16 Clear Lake Development Group Composition and method of immobilizing emetics and method of treating human beings with emetics
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
WO2002094172A2 (fr) * 2001-05-22 2002-11-28 Euro-Celtique Forme posologique compartimentee
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US7524515B2 (en) * 2003-01-10 2009-04-28 Mutual Pharmaceuticals, Inc. Pharmaceutical safety dosage forms
CA2536816A1 (fr) * 2003-08-12 2005-03-03 Endo Pharmaceuticals, Inc. Procede permettant d'empecher l'abus d'opioides par combinaison avec une formulation non liberable d'emetique

Also Published As

Publication number Publication date
EP1893183A4 (fr) 2010-08-18
EP1893183A1 (fr) 2008-03-05
CA2612044A1 (fr) 2006-12-28
WO2006138278A1 (fr) 2006-12-28
JP2008543851A (ja) 2008-12-04

Similar Documents

Publication Publication Date Title
US9060950B2 (en) Emetic embedded capsule
AU2005305232B2 (en) Non-gelatin soft capsule system
US7524515B2 (en) Pharmaceutical safety dosage forms
EP1868585B1 (fr) Capsules a l'epreuve d'abus
CA2612044C (fr) Capsule contenant un emetique
US20150250733A1 (en) Oral drug delivery formulations
Gauri et al. Fast dissolving drug delivery and its technologies.
JP2006016395A (ja) 薬物依存の処置に使用する薬物の安全な投与用の薬学的処方及び薬学的処方の取得方法
US10166207B2 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO1995002395A1 (fr) Formes posologiques encapsulees
EP0706381A1 (fr) Particules encapsulees dans une enveloppe souple en gelatine
US10357461B2 (en) Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition
Ubhe et al. A brief overview on tablet and it’s types
EP1177788B1 (fr) Composition pharmaceutique à base de fluoxétine sous forme de comprimés enrobés dispersibles et son procédé de fabrication
JPH06508633A (ja) ブラインド経口投与形態の製造及び投与方法並びにそのためのブラインド経口投与形態
US20230372329A1 (en) Device for Deterring Abuse of Drugs
Vadivelu et al. The clinical applications of extended-release abuse-deterrent opioids
JP2006515603A (ja) 粉末医薬組成物
WO2016084099A1 (fr) Composition de capsule en gélatine souple d'agents antitussifs
US20190343770A1 (en) Hard Capsule Shell Compositions for the Oral Contraceptive Formulations
CN101296687A (zh) 用于系统性药物的口服载体
US6926906B2 (en) Orally administrable pharmaceutical formulation
CN110022868A (zh) 含减肥药的缓释片剂
SK3496A3 (en) A gelatin capsule
US20180256671A1 (en) Hard Capsule Shell Compositions for the Treatment of Irritable Bowel Syndrome

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20190613